These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7832286)

  • 1. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
    Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
    Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
    von Kaisenberg CS; Krenn V; Ludwig M; Nicolaides KH; Brand-Saberi B
    Anat Embryol (Berl); 1998 Feb; 197(2):105-24. PubMed ID: 9497154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.
    Brand-Saberi B; Epperlein HH; Romanos GE; Christ B
    Cell Tissue Res; 1994 Sep; 277(3):465-75. PubMed ID: 7954686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region.
    Suchet IB
    Can Assoc Radiol J; 1995 Oct; 46(5):344-52. PubMed ID: 7552826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls.
    von Kaisenberg CS; Wilting J; Dörk T; Nicolaides KH; Meinhold-Heerlein I; Hillemanns P; Brand-Saberi B
    Mol Hum Reprod; 2010 Oct; 16(10):778-89. PubMed ID: 20457798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
    Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
    J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
    Böhlandt S; von Kaisenberg CS; Wewetzer K; Christ B; Nicolaides KH; Brand-Saberi B
    Hum Reprod; 2000 May; 15(5):1155-8. PubMed ID: 10783369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonographic identification of second-trimester fetuses with Down's syndrome.
    Benacerraf BR; Gelman R; Frigoletto FD
    N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
    von Kaisenberg CS; Nicolaides KH; Brand-Saberi B
    Hum Reprod; 1999 Mar; 14(3):823-6. PubMed ID: 10221720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
    Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
    Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous resolution of fetal cystic hygroma in Down's syndrome.
    Rodis JF; Vintzileos AM; Campbell WA; Nochimson DJ
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):976-7. PubMed ID: 2967453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal neck edema--early sonographic indications of a chromosome abnormality].
    Voigt HJ; Claussen U; Ulmer R
    Geburtshilfe Frauenheilkd; 1986 Dec; 46(12):879-82. PubMed ID: 2950017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal fibroblasts from Down's syndrome patients share a cycloheximide-induced deficiency in collagen adhesion responses with normal aging cells.
    Flickinger KS; Culp LA
    Exp Cell Res; 1990 Aug; 189(2):189-201. PubMed ID: 2142462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.